Calumet Deferred Long Term Liab from 2010 to 2024
| CLMT Stock | USD 21.40 0.43 1.97% |
Deferred Long Term Liabilities | First Reported 2011-06-30 | Previous Quarter 82.3 M | Current Value 119.7 M | Quarterly Volatility 25.4 M |
Check Calumet Specialty financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Calumet Specialty's main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.3 M, Interest Expense of 232.8 M or Selling General Administrative of 154 M, as well as many indicators such as Price To Sales Ratio of 0.26, Dividend Yield of 0.096 or Days Sales Outstanding of 26.35. Calumet financial statements analysis is a perfect complement when working with Calumet Specialty Valuation or Volatility modules.
Calumet | Deferred Long Term Liab |
Latest Calumet Specialty's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Calumet Specialty Products over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Calumet Specialty's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Calumet Specialty's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Calumet Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 42,106,183 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 124.93 | |
| Mean Deviation | 42,102,402 | |
| Median | 31,400,000 | |
| Standard Deviation | 52,603,992 | |
| Sample Variance | 2767.2T | |
| Range | 144.5M | |
| R-Value | 0.87 | |
| Mean Square Error | 733.8T | |
| R-Squared | 0.75 | |
| Significance | 0.000027 | |
| Slope | 10,212,122 | |
| Total Sum of Squares | 38740.5T |
Calumet Deferred Long Term Liab History
About Calumet Specialty Financial Statements
Calumet Specialty shareholders use historical fundamental indicators, such as Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Calumet Specialty investors may analyze each financial statement separately, they are all interrelated. The changes in Calumet Specialty's assets and liabilities, for example, are also reflected in the revenues and expenses on on Calumet Specialty's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 137.7 M | 144.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.